Build Your Cardiovascular Strategic Alliances with Ohio
Ohio is the best place in the world to optimize the growth of your cardiovascular company because we can imbed you in an asset base that allows you to maximize your business strategy. And BioOhio knows Ohio’s assets, incentive programs, and corporate, academic, state, and local contacts better than anyone. We can be the strategic alliance connection for your company’s site selection, talent recruitment, supplier network, expansion, and partnership needs. Now, onto Ohio’s cardio assets…
Cleveland Clinic: U.S. News’ #1 Heart and Heart Surgery Hospital
Ohio has the most Top Ranked Hospitals by Thomson Reuters 2004-2009 (70)
Ohio hosts 17% of clinical trials in the U.S. – 3,740 active and recruiting as of February 2010
Ohio’s extensive supply chain includes 1,253 bioscience firms, over 1,000 dedicated suppliers, and more than 150 companies with a cardiovascular focus, like: Amersham (GE Health) | Barr Pharmaceuticals | Battelle | Bedford Laboratories | Boehringer Ingelheim’s Ben Venue & Roxane Laboratories | Cardinal Health | Ethicon Endo-Surgery (J&J) | Greatbatch | Hitachi Medical Systems America | Atricure, Inc. | Philips Medical Systems | Abbott Nutrition | ScottCare | Smiths Medical | Steris | and more
Labor, energy, building, and transportation costs are up to 20% below coastal cities
World-Class Cardiovascular Leaders in Ohio
Delos M. Cosgrove, MD, CEO, The Cleveland Clinic
William T. Abraham, MD, Davis Heart and Lung Center at Ohio State
Andrew J. Ringer, MD, University of Cincinnati
Steven E. Nissen, MD, The Cleveland Clinic, American College of Cardiology
Dean J. Kereiakes, MD, Linder Center at Christ Hospital
New Ohio tax code encourages business investments, and rewards companies for global selling
- Eliminates tangible personal property tax and corporate franchise tax
- Exemption from taxation sales outside the state of Ohio (i.e. exports)
Bioscience Funding
- More than $7.9 billion in funding to bioscience entities in 2004-2008 (VC, Angel, NIH, SBIR, NSF, etc.).
- Over 150 healthcare seed/venture funds financed more than 128 Ohio bioscience companies since 2004.
$588M Committed to Ohio’s Public-Private Cardiovascular Partnerships:
Atrial Fibrillation Innovation Center at the Cleveland Clinic
- $70.2 million investment to ensure that new atrial fibrillation therapies quickly come to market for the benefit of atrial fibrillation sufferers utilizing state of the art cardiac mapping and experimental labs
- Collaborators include AtriCure, Case Western Reserve University and University of Cincinnati
Cardiovascular Bioengineering Enterprise at OSU
- $61.8 million investment to facilitate imaging breakthroughs in diagnostic capability and anatomic resolution to provide enhanced risk assessment for the detection and treatment of atherosclerotic disease
- Collaborators include Battelle, Berlex, GE Medical Systems, and Siemens
Genome Research Institute at the University of Cincinnati
- $46.3 million investment to fund a state and regional hub for gene and protein profile analysis, bioinformatics software development and medicinal chemistry with a focus on cardiovascular disease, metabolic disorders, cancer, and neurology
- Collaborators include Procter & Gamble Pharmaceuticals, The Air Force Research Laboratory at Wright Patterson Air Force Base, Cincinnati Children’s Hospital and Wright State University
Global Cardiovascular Innovation Center at the Cleveland Clinic
- $250 million investment, seeded with a $60 million grant from the State of Ohio to significantly accelerate the commercialization of cardiovascular products
- Collaborators include Case Western Reserve Medical Center, GE Healthcare, IBM, Medtronic, Pfizer, P&G, The Ohio State University, University of Cincinnati, University of Toledo
National Center for Regenerative Medicine at Case Western Reserve University
- $71.9 million investment to translate innovative laboratory research into the clinical and commercial arenas to replace and repair diseased tissues and organs
- Partners are The Cleveland Clinic Foundation, and University Hospitals of Cleveland
381 new plants and expansions in 2009, more than anywhere else in U.S.
- Ohio has won the Site Selection Governor's Cup 4 years running (06-09)
- 4th largest interstate highway system in U.S. Ohio is within a day’s drive of 80% of U.S. Corporate Headquarters and 63 percent of U.S. manufacturing facilities
- 10 designated Foreign Trade Zones
World-Class Research
5 institutions – Case Western Reserve University, The Ohio State University, University of Cincinnati, Cincinnati Children’s Hospital and Cleveland Clinic rank in the top 100 NIH funding recipients.
Informatics Prowess
- Ohio Supercomputer Center – a resource for computational high performance computing and networking
- OSCnet – 1,600-mile fiber optics network, the most advanced research and education network in the nation
- daytaOhio – a $14M Wright Center of Innovation for advanced data management and analysis
Building Your Cardiovascular Strategic Alliances with Ohio and BioOhio
This is only a snapshot of the cardio related facts across Ohio. Contact BioOhio, Ohio’s bioscience development organization, to learn more and to discuss bi-directional investment opportunities and how building strategic alliances with Ohio can impact your bottom line.